MSB 2.29% $1.28 mesoblast limited

Cell Therapy News/Articles, page-4435

  1. 327 Posts.
    lightbulb Created with Sketch. 1340
    "More evidence suggests no long-term COVID-19 immunity"

    So the magic bullet is not going to be vaccine. At least part of the solution would lie in therapeutics, like Remestemcel-L produced by Mesoblast.

    https://hotcopper.com.au/data/attachments/2297/2297517-e410456111a8ad66bbc7ff6d7e0c73a6.jpg
    https://hotcopper.com.au/data/attachments/2297/2297519-f3fa32545697416ca1adfc243430a634.jpg
    https://hotcopper.com.au/data/attachments/2297/2297522-e621b6859c0cfa9d739df03ddb007a91.jpg
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.28
Change
-0.030(2.29%)
Mkt cap ! $1.461B
Open High Low Value Volume
$1.32 $1.35 $1.28 $1.677M 1.289M

Buyers (Bids)

No. Vol. Price($)
10 44452 $1.28
 

Sellers (Offers)

Price($) Vol. No.
$1.29 23596 1
View Market Depth
Last trade - 16.10pm 04/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.